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Abstract
The currently established linear nontreshold (LNT) risk model is used for radiation pro-
tection and is actually not intended for risk assessment. Also dose concepts such as effec-
tive dose are constructions used for radiation protection, focusing on the regulatory use 
in standards for workers but is seldom useful for members of the public. Both the LNT 
model, as well as use of the concept effective dose, are also not applicable in the low dose 
area. An alternative method for public health risk assessment and disease surveillance 
can be the combination of environmental radiation monitoring and health databases. For 
example, after the Chernobyl accident, airborne measurements of cesium-137 gamma 
spectrum from the ground, activity data from food samples and high quality national 
health registries were used for the risk assessment of cancer development.
Keywords: cancer, health surveillance, ionizing radiation, nuclear accident, risk 
assessment
1. Introduction
The golden standard for risk assessment of health effects from ionizing radiation are mor-
tality data from the LSS (Life Span Study) cohort of survivors after the atomic bombings in 
Hiroshima and Nagasaki in 1945. Based on epidemiological data from the 93,000 survivors, 
the currently accepted linear nontreshold (LNT) risk model has been established. There are 
however several important shortcomings of this model. Firstly the LSS cohort is mainly 
based on mortality data. It is well-known that mortality data is inexact in diagnostic criteria, 
mostly lacking autopsy data. Cancer registries for cancer incidence data using histologically 
verified sampling have better diagnostic accuracy. Secondly the LSS cohort is based on acute 
exposure at the time of the bombing, but very little chronic exposure due to local fallout. 
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Most radioactivity was spread in the atmosphere after the bombings giving relatively little 
local fallout. Thirdly the LNT model is poorly verified in the so called low dose region 
(<100 mGy/mSv). A recent follow-up of the LSS-cohort after 52 years point at uncertainties 
of the shape of the dose response curve supporting a linear-quadratic model [1]. Perhaps 
the most debated detail about the LNT model is the introduction of a risk reduction for 
the low dose region. The so called “dose and dose-rate effectiveness factor”, DDREF, sug-
gest that the risk of malignancy should be lowered by a factor of 2 in the low dose region 
(<100 mSv) introduced by the International Commission on Radiological Protection (ICRP). 
The theoretical argument for this arbitrary halving of risk estimates was that cellular repair 
mechanisms ought to be more efficient at low doses and low dose-rates. Perhaps a corrected 
radiation risk model will be considered in the light of new data and based on both physical, 
epidemiological and biologic data. Most other biological, medical and toxicological systems 
have exponential or s-shaped relationships between exposure and outcome, instead of lin-
ear. Models for radiation protection are also made mainly for regulatory purposes and do 
not directly reflect risk of disease, especially for exposures to populations in the low dose 
region. Therefore, nuclear accidents, such as in Harrisburg, Chernobyl or Fukushima, differ 
substantially from the conditions on which the LSS cohort and the LNT model are based. 
Other approaches using national health databases and environmental monitoring to detect 
health risks might be useful.
2. Assessment of dose
2.1. Uncertainties in dose measurements
The currently used dose estimates, such as equivalent dose or effective dose, are constructions 
used for radiation protection, focusing on the regulatory use in standards for workers but are 
seldom useful for members of the public. These dose estimates make use of several weighing 
factor, depending on type of radiation and the organ affected.
However, environmental exposure are often complex, including multiple tissues or whole 
body exposure. It is also often a combination of both external and internal exposure. For 
that purpose the International Commission on Radiological Protection (ICRP) recommends a 
weighing factor for effective dose, specific for 14 different organ/tissue categories. This weigh-
ing factor is based on years of life lost and also genetic effects, rather than the biological risk of 
cancer development. As a consequence thyroid cancer is weighed one third of bone marrow 
malignancy, breast cancer and stomach cancer, which is not related to the biological risk of 
developing a malignancy from a certain radiation dose.
The currently used dose estimates are primarily not constructed to be used in epidemiological 
studies on cancer incidence, since the weighing factors are evaluating the severity of health out-
comes, mortality and even genetic effects. Therefore a discussion should be introduced about 
what dose risk estimates might be more suitable for epidemiological studies of cancer incidence, 
for example using absorbed dose energy with both radiophysically and biologically based cor-
rection factors.
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2.2. Alternative biological dosimetry techniques
There are no biological markers for the assessment of low dose or low dose-rate exposes to 
humans [2]. After receiving larger external doses, nail and tooth enamel magnetic resonance 
analysis might be used, though with a large inaccuracy of dosimetry of 30–50 mGy, high costs 
and advanced laboratory equipment limiting the practical use [3]. Examples of other physical 
and biological dosimetry techniques being evaluated, though not yet practically applicable 
are: protein biomarkers, hematological changes, chromosomal damages, micronuclei and 
thermoluminescence [4].
2.3. Indirect dose assessment in non-occupational populations
Personal dosimetry is mainly used for the protection of radiation workers to ensure that the 
exposure to ionizing radiation is kept within dose equivalent limits. When a larger popula-
tion is exposed to radionuclides dosimeters are not available in sufficiently large numbers. An 
exception is the internal dose to the thyroid gland which can be accessed via direct thyroid 
scans of radio-iodine uptake. The external dose contribution and the contributions from other 
radionuclides are more difficult to assess, especially multi-organ or whole-body doses.
Instead environmental monitoring from both stationary and mobile dosimeters can map geo-
graphical patterns of contamination. From these environmental data indirect dose assessments 
can be calculated for larger populations. External radiation doses to a population can be esti-
mated via deposition maps, meteorological modeling or distance from the radiation source, 
including factors such as shielding. Internal doses can be measured for a limited amount of 
subjects via whole-body counting or thyroid scanners, but for most of the population esti-
mations of doses can be made based on residence, inhalation and ingestion assumptions. 
An example of a well-developed model for indirect dose assessment is the Radiation Effects 
Research Foundation (RERF) dose estimation model (DS02R1) from an atomic bomb. The 
model takes into account distance to the hypocenter, shielding from buildings and terrain [1].
2.4. An example of indirect dose assessment among Swedish hunters
Using transfer factors based on whole-body counting  from the Swedish  population an example 
of a model for the assessment of life-time (70 years) extra dose from the Chernobyl fall-out was 
calculated for 16,000 hunters with families in the three mostly contaminated counties in Sweden. 
An extra life-time dose up to 9.4 mSv was calculated, depending on the factors age, gender and 
habitat. About 75% of the life-time dose was from internal contamination from food [5].
If only the external dose contribution is accounted for during the first year the relative dose 
contribution from so called short-lived fission products was 36%, 37% for cesium-134 and 
27% for cesium-137. After 70 years the proportions were 11%, 29% and 60% respectively [6].
2.5. Dose assessment among reindeer herders
The highest radionuclide exposure to a population outside the former Soviet Union after the 
Chernobyl accident was received among Nordic reindeer herders, receiving about 10–100 
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times higher doses than urban populations, according to Swedish whole-body counts [7]. The 
reindeer livelihood was severely affected by the Chernobyl fall-out. Due to radiation protec-
tion actions about 80% of the Swedish reindeer meat was destroyed the first years following 
the accident, and the slaughter had to be moved from winter season to summer, when browse 
was less contaminated. Middle aged reindeer herdsmen also received similar or even higher 
doses from the global fall-out during the 1950ies and 1960ies making them exposed twice [8]. 
According to population data from Statistics Sweden there are only about 700 reindeer herd-
ers by occupation in Sweden, which gives too low power for epidemiological analyses on 
cancer incidence, but a combined study from all Nordic countries might be possible.
3. Use of national health data registries
Although the LSS-cohort outcome is the supposedly golden standard for cancer risk 
there is a fundamental shortcoming due to lack of early data covering the Hiroshima and 
Nagasaki prefecture populations, since prefecture cancer registries were not in use until 
1958. Furthermore the LSS-cohort is mainly based on mortality data although cancer inci-
dence registries usually are based on histological sampling with higher diagnostic accu-
racy. This gives uncertainties to the LSS-data concerning early health effects for the cancer 
risk models. In japan a “National Health Promotion” law put in place in Japan in the early 
2000s said that prefectures must track illnesses including cancer. This law led to the intro-
duction of some new cancer registries in Japan. The Fukushima prefecture begun a cancer 
registry in 2010 using a standardized database system governed by the Japanese National 
Cancer Center. But the data produced in the first few years the cancer registry was of poor 
quality and is still being developed by the year 2017. This is a great drawback for the esti-
mation of health outcomes, including cancer, for the population of the Fukushima prefec-
ture following the nuclear accident in 2011.
The lack of official health data or a national health data base were even more striking in 
the former Soviet union at the time of the Chernobyl accident in 1986. The absence of data 
for researchers has made follow-up of health outcomes difficult in the former Soviet states, 
though national cancer registries are now built up in Belarus, Ukraine and the Baltic states.
In the Nordic countries there are national cancer registries at the individual level covering all 
population. In Sweden a national cancer registry is in use since 1958 [9]. Good quality cancer 
registries make it possible to register changes in baseline incidences following environmental 
changes such as radio-nuclide releases to the population, especially as a complement when 
dosimetry is absent or very inexact.
3.1. The example of detecting increased cancer incidence in South Wales around 
Windscale
The first population study apart from the LSS-cohort showing a possible increased risk of can-
cer was in South Wales. From a fuel reprocessing plant at Windscale waste was discharged into 
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the Irish See via a pipeline and deposition occurred in the sea bottom, fish and sea weed. The 
fission product ruthenium-106 was taken up very efficiently and concentrated in the sea weed 
Porphyra umbilicales. It was harvested and used in laver bread, consumed mainly in South Wales. 
The use had to be stopped. The activity in fish was mainly from cesium-137. When an ecosys-
tem is contaminated with radionuclides and local food is the main source of internal exposure 
to radiation the individual doses to the population are very difficult to assess since food hab-
its and lifestyle differ fundamentally between individuals and regions. Whole-body counting 
can be made to a small sample of the population, mainly concerning gamma-radiation from 
gamma-emitting nuclides and indirectly from alpha-emitters with gamma-decay, but has 
lower sensitivity for detecting the beta-radiation, such as from ruthenium-106. Therefore health 
surveillance via national cancer registries was fundamental to monitor the health effects to the 
population with an ecosystem is contaminated by radionuclides. Several epidemiological stud-
ies have shown increased incidences of cancer of the population around Windscale [10].
3.2. The example of detecting increased cancer incidence for people living at the 
Techa river
In 1949 the Mayak Production Association, located in the Southern Urals, started production of 
plutonium for the Soviet Nuclear weapons program. A cohort of 30,000 residents of 40 rural vil-
lages along the Techa river or the Chelyabinsk City with low-dose and low-dose-rate exposures 
have been followed for more than 50 years for incident cases of cancer. Individual radiation 
doses were based on geographic information of residence and food habits. Calculated external 
exposures were due to gamma rays from contamination of the soil and the internal exposures 
were assessed from expected consumption of water, milk and food containing uranium fission 
products. All solid cancers as a group were related to stomach doses ranging from 0 to 960 mGy 
with a mean of 60 mGy. Dose–response between estimated radiation dose and solid cancers and 
leukemia were shown with an excess relative risk (ERR) after exposure to 100 mGy of 0.08 [11].
3.3. The example of detecting increased incidence of thyroid cancer in Ukraine after 
the Chernobyl accident
Chemical composition, deposition, uptake and metabolism of iodine make thyroid dosimetry 
complicated, but direct measurement using a gamma-meter of the thyroid gland can be made. 
To estimate individual thyroid absorbed doses from radioiodine in the Ukrainian population 
from May–June 1986, more than 150,000 individual examinations were carried out by spe-
cial dosimetric teams. The collective thyroid dose was 64,000 person-Gy, which theoretically 
could give about 300 extra cases of thyroid cancer [12].
Another study was performed on behalf of the International Agency for Research on Cancer 
(IARC). A population-based case–control study was designed of thyroid cancer among young 
people who lived in the areas that were heavily contaminated by the Chernobyl accident, Indirect 
dosimetry was performed based on data of the habitat and dietary habits of 1615 cases and con-
trols aged 0–18 y at the time of the accident. A strong dose–response relationship was observed 
between estimated radiation dose to the thyroid received in childhood and thyroid cancer risk [13].
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3.4. The example of detecting increased cancer incidence in Sweden after the 
Chernobyl accident
Sweden received the largest deposition of radionuclides outside the former USSR, where about 
4.4% of the total Chernobyl fall-out was deposited [14]. Deposition was strongly dependent on 
local weathering giving highest deposition in coastal areas around the Bothnian sea. A food 
regulation program was introduced to assure that the annual extra dose did not exceed 1 mSv 
in the population. In a study indirect individual doses were assessed for 734,537 persons living 
in the three most contaminated counties in Sweden. Personal dosimetry could not be performed 
30 years after the accident, so a cumulative exposure based on measured ground activity of 
cesium-137 of the residence of the subjects. A cumulative exposure estimate during 5 years fol-
lowing the accident was used as proxy for received dose. 82,495 cases of cancer were diagnosed 
from 1991 to 2010 and retrieved from the Swedish national cancer registry. A non-parametric 
dose–response could be shown between the deposition of cesum-137 and cancer incidence [15].
4. Conclusion
A paradigm shift is needed from the dominance of radiation protection to a more biologically 
based health risk assessment from ionizing radiation. Models for radiation protection are made for 
regulatory purposes and do not directly reflect the risk of disease. Also dose estimates are poorly 
applicable for risk assessment for populations exposed in the low dose region. Only to rely on tech-
nical surveillance could be insufficient. Instead other approaches using national health databases 
in combination with environmental monitoring could be more efficient for the detection of health 
risks. Medical surveillance and health registries are good complements, especially in the absence of 
dosimeter data, complex environmental exposures and when large populations are exposed. When 
nuclear facilities are in use national health registries could be the most sensitive source for the detec-
tion of increased cancer incidence and other disease from nuclear accidents or other emission of 
radionuclides to the environment. Apart from nuclear power plants possible exposure could ema-
nate from uranium mining, fuel processing, nuclear waste processing and nuclear waste repositories.
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